|
 |
|
 |
|
1) |
What is Herpes? |
| |
Herpes simplex viruses produce a variety of infections involving mucocutaneous surfaces, the central nervous system, and occasionally visceral organs. The advent of effective antiviral chemotherapy for herpes simplex virus infections has made prompt recognition of these syndromes of clinical importance. |
2) |
How to identify Herpes? |
| |
First-episode primary genital herpes is characterized by fever, headache, malaise, and myalgias. Pain, itching, dysuria, vaginal and urethral discharge, and tender inguinal lymphadenopathy are the predominant local symptons. |
3) |
Available treatment for Herpes |
| |
For mucocutaneous infections, acyclovir has been the mainstay of therapy. Acyclovir has been shown to be effective in shortening the duration of symptoms and lesions of mucocutaneous herpes infections in immunocompromised patients and first-episode genital herpes in immunocompetent patients. However, drug resistance to acyclovir has become an issue. ZHAOKE Yallaferon, has successfully completed clinical trial for treatment of herpes and shown to be an effective alternative for treatment of Herpes. |
4) |
Prevalency |
| |
According to the statistics of the 1998 Nationwide Venereal Disease Report, genital herpes ranked fifth with an annual growth rate of 31.40%. The World Health Organization estimates that, due to common avoidance of seeking face to face medical consultations by Chinese patients who contact venereal diseases, coupled with common omissions from reporting thereby owing to personal embarrassment, the official reported cases of venereal diseases may only represent about 20 to about 25% of the actual total number of cases. |
|
|
|
|
